Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Sperling RS, et al. Among authors: jimenez e. N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201. N Engl J Med. 1996. PMID: 8965861 Free article. Clinical Trial.
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
Lambert JS, Watts DH, Mofenson L, Stiehm ER, Harris DR, Bethel J, Whitehouse J, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H, van Dyke R, Maupin R, Silio M, Fowler MG. Lambert JS, et al. Among authors: jimenez e. AIDS. 2000 Jul 7;14(10):1389-99. doi: 10.1097/00002030-200007070-00012. AIDS. 2000. PMID: 10930154 Clinical Trial.
Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team.
Bakshi SS, Britto P, Capparelli E, Mofenson L, Fowler MG, Rasheed S, Schoenfeld D, Zimmer B, Frank Y, Yogev R, Jimenez E, Salgo M, Boone G, Pahwa SG. Bakshi SS, et al. Among authors: jimenez e. J Infect Dis. 1997 May;175(5):1039-50. doi: 10.1086/520351. J Infect Dis. 1997. PMID: 9129064 Clinical Trial.
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J. Culnane M, et al. Among authors: jimenez e. JAMA. 1999 Jan 13;281(2):151-7. doi: 10.1001/jama.281.2.151. JAMA. 1999. PMID: 9917118 Clinical Trial.
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J Jr, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H. Stiehm ER, et al. Among authors: jimenez e. J Infect Dis. 1999 Mar;179(3):567-75. doi: 10.1086/314637. J Infect Dis. 1999. PMID: 9952362 Clinical Trial.
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.
Brady MT, McGrath N, Brouwers P, Gelber R, Fowler MG, Yogev R, Hutton N, Bryson YJ, Mitchell CD, Fikrig S, Borkowsky W, Jimenez E, McSherry G, Rubinstein A, Wilfert CM, McIntosh K, Elkins MM, Weintrub PS. Brady MT, et al. Among authors: jimenez e. J Infect Dis. 1996 May;173(5):1097-106. doi: 10.1093/infdis/173.5.1097. J Infect Dis. 1996. PMID: 8627060 Clinical Trial.
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.
Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL. Mirochnick M, et al. Among authors: jimenez e. J Infect Dis. 1998 Aug;178(2):368-74. doi: 10.1086/515641. J Infect Dis. 1998. PMID: 9697716 Clinical Trial.
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.
Winter HS, Oleske JM, Hughes MD, McKinney RE Jr, Elgie C, Powell C, Purdue L, Puga AM, Jimenez E, Scott GB, Cruz ML, Moye J Jr; Pediatric AIDS Clinical Trials Group Protocol 247 Study Team. Winter HS, et al. Among authors: jimenez e. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):222-32. doi: 10.1097/MPG.0b013e3181928937. J Pediatr Gastroenterol Nutr. 2009. PMID: 19543114 Free PMC article. Clinical Trial.
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.
Borkowsky W, Wara D, Fenton T, McNamara J, Kang M, Mofenson L, McFarland E, Cunningham C, Duliege AM, Francis D, Bryson Y, Burchett S, Spector SA, Frenkel LM, Starr S, Van Dyke R, Jimenez E. Borkowsky W, et al. Among authors: jimenez e. J Infect Dis. 2000 Mar;181(3):890-6. doi: 10.1086/315298. J Infect Dis. 2000. PMID: 10720509 Clinical Trial.
1,271 results